Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study.
Ehmsen S, Jakobsen LH, Lendorf ME, Eefsen RL, Bentsen L, Knoop AS, Aggerholm-Pedersen N, Skuladottir H, Herrstedt J, Jensen LH, Rotbøl C, Damm MB, Wedervang K, Glenthøj A, Ryg J, Frederiksen H, Kodahl AR. Ehmsen S, et al. Among authors: wedervang k. Acta Oncol. 2021 Jul;60(7):859-865. doi: 10.1080/0284186X.2021.1889659. Epub 2021 Mar 1. Acta Oncol. 2021. PMID: 33646071
Sino-nasal cancer in Denmark 1982-1991--a nationwide survey.
Grau C, Jakobsen MH, Harbo G, Svane-Knudsen V, Wedervang K, Larsen SK, Rytter C. Grau C, et al. Among authors: wedervang k. Acta Oncol. 2001;40(1):19-23. doi: 10.1080/028418601750070993. Acta Oncol. 2001. PMID: 11321654
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy.
Mouritzen MT, Carus A, Ladekarl M, Meldgaard P, Nielsen AWM, Livbjerg A, Larsen JW, Skuladottir H, Kristiansen C, Wedervang K, Schytte T, Hansen KH, Østby AC, Frank MS, Lauritsen J, Sørensen JB, Langer SW, Persson GF, Andersen JL, Frary JMC, Drivsholm LB, Vesteghem C, Christensen HS, Bjørnhart B, Pøhl M. Mouritzen MT, et al. Among authors: wedervang k. Cancers (Basel). 2021 Sep 28;13(19):4846. doi: 10.3390/cancers13194846. Cancers (Basel). 2021. PMID: 34638329 Free PMC article.
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
Mouritzen MT, Junker KF, Carus A, Ladekarl M, Meldgaard P, Nielsen AWM, Livbjerg A, Larsen JW, Skuladottir H, Kristiansen C, Wedervang K, Schytte T, Hansen KH, Østby AC, Frank MS, Lauritsen J, Sørensen JB, Langer SW, Persson GF, Andersen JL, Homann PH, Kristensen EB, Drivsholm LB, Bøgsted M, Christensen HS, Pøhl M, Bjørnhart B. Mouritzen MT, et al. Among authors: wedervang k. Acta Oncol. 2022 Apr;61(4):409-416. doi: 10.1080/0284186X.2021.2023213. Epub 2022 Jan 11. Acta Oncol. 2022. PMID: 35012430
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan.
Mau-Sørensen M, Gerner-Rasmussen J, Hansen O, Holm B, Nyhus CH, McCulloch T, Nielsen HA, Wedervang K, Rytter C, Jeppesen N, Langer SW. Mau-Sørensen M, et al. Among authors: wedervang k. Acta Oncol. 2023 Dec;62(12):1979-1982. doi: 10.1080/0284186X.2023.2278173. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37934081 Clinical Trial. No abstract available.
The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer.
Langkjer ST, Kenholm J, Jensen JD, Wedervang K, Brixen AT, Grunnet M, Stenbygaard L, Gilje B, Danø H, Glavicic V, Jacobsen EH, Brems-Eskildsen AS, Kruse HL, Dongsgaard T, Neimann J, Geisler J. Langkjer ST, et al. Among authors: wedervang k. Future Oncol. 2019 Aug;15(22):2561-2569. doi: 10.2217/fon-2019-0124. Epub 2019 Jun 19. Future Oncol. 2019. PMID: 31215242 Free article. Clinical Trial.